Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04629014

Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure

Status
Recruiting
Phase
Study type
Observational
Enrollment
750 (estimated)
Sponsor
Boston Children's Hospital · Academic / Other
Sex
All
Age
6 Months – 25 Years
Healthy volunteers
Not accepted

Summary

This study proposes to quantify and describe the quality of life of children with intestinal failure, and to identify the medical and socio-economic factors that impact this quality of life, using data from multiple multidisciplinary intestinal failure centers across the United States and Canada specializing in the care of these participants.

Detailed description

Health related quality of life is becoming an increasingly important topic as medical advancements continue to increase life expectancies in various illnesses. Quality of life (QoL) encompasses the physical, psychological, and social well-being of a person. Studies focusing on health related QoL show that providers have a limited understanding of the QoL of their patients, demonstrating a need for further research. Mortality rates in pediatric intestinal failure (PIF) have significantly dropped over the past 3-4 decades and long-term morbidity rather than survival has come into focus as the outcome of interest. However, there remains a significant knowledge gap regarding the specific factors that contribute to QoL among PIF patients and their families. Insight into the challenges these patients face can promote enhanced support services and psycho-education for caregivers of these children as well as help to tailor medical and surgical treatment with a focus on improved QoL. Due to the rare nature of PIF, and despite a recent bloom in multidisciplinary PIF centers, experience is limited in individual centers and a multi-site study with a robust and diverse patient population is optimal to study QoL in pediatric intestinal failure.

Conditions

Timeline

Start date
2020-02-27
Primary completion
2029-12-01
Completion
2029-12-01
First posted
2020-11-16
Last updated
2026-03-23

Locations

14 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT04629014. Inclusion in this directory is not an endorsement.